The Problem: Dozens of AI Pilots, Zero Scale
Many pharmaceutical companies have launched dozens of AI pilots across R&D, Commercial, Manufacturing, and IT. Yet very few have scaled beyond proof-of-concept. The missing ingredient is rarely technology — it is strategy: a clear articulation of where AI creates the most value, how it fits into the operating model, and what governance frameworks ensure responsible deployment in a regulated industry. Without strategy, AI investment becomes scattered, duplicative, and ultimately disappointing.
The Solution: Business-Back AI Prioritization
Our framework starts with business-back prioritization: mapping AI use cases to specific value pools across the pharma value chain. Each use case is scored on value potential, feasibility (data readiness, technical complexity), and regulatory risk. The output is a sequenced roadmap with quick wins that build organizational confidence, medium-term initiatives that deliver substantial ROI, and strategic bets that position the company for long-term competitive advantage.
The Approach: Strategy That Leads to Action
- AI use case portfolio mapping across R&D, Commercial, Manufacturing, and Corporate IT
- Data maturity assessment and remediation plan
- AI operating model design: centralized CoE vs. federated vs. hybrid
- Governance framework aligned with EU AI Act and Swiss nDSG requirements
- Talent and capability building strategy
- Vendor and technology stack evaluation
The best AI strategies start with business problems, not technology solutions. The question is never "how do we use AI?" but "where does AI create measurable value?"
How ANG Associates Can Help
ANG Associates is uniquely positioned to develop AI strategy roadmaps for pharma organizations because we combine three capabilities that are rarely found together: deep Life Sciences domain expertise (we understand the regulatory, scientific, and commercial context), AI and ML knowledge (we know what's technically feasible and what's hype), and proven IT delivery management (we know how to turn strategy into executed programs). We don't just write strategy decks — we build actionable roadmaps with governance frameworks, operating model designs, and delivery plans that our clients can execute.